↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

23 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Ademetionine  0件:   D07128   -   -   15件:
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172
 2   Carmustine  2件: Carmustine; Carmustine, etoposide, cytarabine, and melphalan (beam);   D00254   -   -   5件:
11,
13,
14,
28,
60
 3   Chloride ion  0件:   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299
 4   Ciclosporin  7件: Ciclosporin; Ciclosporina; Ciclosporine; Aerolised liposomal ciclosporin a; Ciclosporin (ciclosporinium); Ciclosporin a; Ciclosporine, ciclosporina;   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   44件:
11,
14,
19,
20,
26,
28,
36,
38,
39,
40,
41,
42,
45,
46,
49,
50,
53,
55,
56,
58,
60,
61,
62,
63,
64,
65,
90,
95,
97,
113,
162,
164,
222,
223,
226,
228,
234,
269,
274,
283,
284,
285,
302,
326
 5   Cyclophosphamide  49件: Cyclophosphamide; Cyclophosphamide (drug); Cyclophosphamide and atg; Cyclophosphamide monohydrate; Cyclophosphamide/glatiramer acetate; Busulfan, cyclophosphamide, antithymocyte globulin; Busulfan, cyclophosphamide, atg; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Lenalidomide, dexamethasone and cyclophosphamide; Rituximab and cyclophosphamide iv; Prednisone, cyclophosphamide; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Cyclophosphamide-prednisone-azathioprine; Iv cyclophosphamide; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Cyclophosphamide (cy); Cyclophosphamide (cy) (plan 1); Cyclophosphamide (cy) (plan 2); Cyclophosphamide 100mg; Cyclophosphamide 150mg; Cyclophosphamide 50mg; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Cyclophosphamide,campath ih and tbi; Cyclophosphamide,cyclosporine a; Fludarabine, cyclophosphamide; Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide''; Busulfan, cyclophosphamide, atg, gcsf; Campath, fludarabine, cyclophosphamide; Cyclophosphamide 30; Cyclophosphamide 40; Cyclophosphamide dose level 1; Cyclophosphamide dose level 2; Cyclophosphamide dose level 3; Cyclophosphamide dose level 4; Cyclophosphamide post transplant; Prednisone and cyclophosphamide; Prednisone plus cyclophosphamide; High-dose cyclophosphamide; Cyclophosphamide 50mg oral tablet; Cyclophosphamide and steroids; Cyclophosphamide(ctx); Cyclophosphamide + pred; Cyclophosphamide, fludarabine; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen); Thalidomide, cyclophosphamide and prednisone;   D00287
 D07760 
 -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331
 6   Cytarabine  2件: Cytarabine; Carmustine, etoposide, cytarabine, and melphalan (beam);   D00168
 D03046
 D03637 
 -   -   6件:
11,
13,
14,
25,
49,
60
 7   Eculizumab  4件: Eculizumab; Abp 959 - biosimilar to eculizumab; Sb12 (proposed eculizumab biosimilar); Soliris (eculizumab);   D03940   1件: C5   1件: Complement and coagulation cascades   7件:
11,
13,
14,
62,
109,
222,
223
 8   Ethanol  14件: Endocannabinoid palmitoylethanolamide (pea); Palmitoylethanolamide; Treprostinil diethanolamine; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate;   D00068
 D02798
 D04855
 D06542 
 -   -   49件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
58,
61,
63,
64,
65,
66,
81,
84,
85,
86,
88,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
279,
280,
283,
284,
285,
288,
298,
299,
300,
331
 9   Etoposide  2件: Etoposide; Carmustine, etoposide, cytarabine, and melphalan (beam);   D00125
 D04107 
 -   -   11件:
11,
13,
14,
26,
28,
34,
60,
65,
85,
164,
331
 10   Fibrinogen Human  0件:   -   -   -   3件:
14,
65,
288
 11   Fingolimod  7件: 0,5 mg fingolimod; Fingolimod; Fingolimod (fty720); Fingolimod 0.5 mg; Fingolimod 1.25 mg; Fingolimod hydrochloride; Fingolimodi;   D10001   1件: S1PR1   2件: Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   4件:
2,
13,
14,
156
 12   Human interferon beta  6件: Human interferon beta; Human interferon beta 1a (rebif); Human interferon beta-1a and glatiramer acetate; New formulation of rebif - human interferon beta-1a; Recombinant human interferon beta; Recombinant human interferon beta-1a;   -   -   -   6件:
13,
14,
20,
26,
96,
97
 13   Immune Globulin Human  0件:   -   -   -   20件:
2,
11,
13,
14,
17,
18,
35,
38,
39,
43,
45,
49,
50,
51,
63,
65,
85,
164,
296,
309
 14   Interferon beta-1a  24件: Avonex (interferon beta-1a), biogen idec ltd; Bg9418 (interferon beta-1a); Biib017 (peginterferon beta-1a); Human interferon beta-1a and glatiramer acetate; Interferon beta-1a; Interferon beta-1a (avonex); Interferon beta-1a (avonex®); Interferon beta-1a (current approved manufacturing process invloving fbs); Interferon beta-1a (new process, manufactured without fbs); Interferon beta-1a (rebif); Interferon beta-1a 30 µg; Interferon beta-1a fbs-free/hsa-free, rnf; Interferon beta-1a hsa+ biosimilar; Interferon beta-1a hsa-free biosimilar; Interferon beta-1a original; New formulation of rebif - human interferon beta-1a; Peginterferon beta-1a; Pegylated interferon beta-1a; Plegridy (peginterferon beta-1a), biogen idec ltd; Rebif (interferon beta-1a); Rebif (interferon beta-1a), merck serono europe ltd; Sc interferon beta-1a; Sc peginterferon beta-1a; Recombinant human interferon beta-1a;   D04554   2件: IFNAR1, IFNAR2   4件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Toll-like receptor signaling pathway   5件:
13,
14,
26,
96,
97
 15   Lipoic Acid  8件: Alpha-lipoic acid; Lipoic acid; Alpha-lipoic acid and l-acetyl carnitine; Alpha lipoic acid; Lipoic acid (la) with fish oil and la without fish oil; Lipoic acid and omega-3 fatty acids; Oral lipoic acid (la); R lipoic acid;   D00048
 D00086 
 -   -   5件:
2,
5,
13,
14,
20
 16   Melphalan  8件: Melphalan; Carmustine, etoposide, cytarabine, and melphalan (beam); Melphalan, thalidomide and dexamethasone; Propylene glycol-free melphalan hydrochloride; Fludarabine/ melphalan; Melphalan hydrochloride; Fludarabine, melphalan, thiotepa; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan;   D00369   -   -   14件:
11,
13,
14,
19,
20,
28,
60,
62,
65,
96,
164,
234,
284,
285
 17   Mycophenolate mofetil  17件: Mycophenolate mofetil; Mycophenolate mofetil (cellcept); Mycophenolate mofetil [cellcept]; Mycophenolate mofetil (mmf) 3 g/day; Mycophenolate mofetil 2 g/day; Cellcept (mycophenolate mofetil); Mycophenolate mofetil,methotrexate; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Mycophenolate mofetil (mmf); Mycophenolate mofetil plus lower dose of prednisone; Azathioprine or mycophenolate mofetil; Mycophenolate mofetil orally 1000 mg twice a day (bid); Mycophenolate mofetil, low dose steroid; Prednisolone and mycophenolate mofetil; Mycophenolate mofetil(mmf); Cyclosporine combine with mycophenolate mofetil; Prednisone and mycophenolate mofetil;   D00752
 D05094
 D05095 
 2件: IMPDH1, IMPDH2   1件: Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300
 18   Mycophenolic acid  2件: Mycophenolic acid; Mycophenolic acid mofetil;   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   34件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
228,
234,
283,
284,
285,
300
 19   Prednisone  59件: Prednisone; Prednisone - azathioprine; Prednisone alone; Granulocyte-colony stimulating factor (g-csf) and prednisone; Prednisone/prednisolone; Prednisone acetate; Prednisone, cyclophosphamide; Over encapsulated prednisone; Prednisone and ustekinumab treatment; Prednisone capsules; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Prednisone (and methylprednisolone); 0 mg prednisone; 5 mg prednisone; Methylprednisone; Prednisone 15 mg; Prednisone 5 mg; Prednisone 7.5 mg; Rayos (delayed-release prednisone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide-prednisone-azathioprine; Oral prednisone 5mg; Prednisone discontinuation; Chinese herb prescription granule plus prednisone; Enalapril valsartan methylprednisone; Hormone (prednisone); Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Mycophenolate mofetil plus lower dose of prednisone; Prednisone + inhibace/cozaar; Prednisone and cyclophosphamide; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Glucocorticoid (prednisone or prednisolone); Hydroxychloroquine + prednisone; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; 5-aminosalicylic acid(5-asa) and/or prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Prednisone 0,5 mg/kg orally on alternate days; Prednisone, fk506, mmf; Tacrolimus combined with prednisone; Prednisone acetate tablets; Oral prednisone; Sotatercept with prednisone boost; Prednisone and mycophenolate mofetil; Thalidomide, cyclophosphamide and prednisone;   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   44件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331
 20   Rituximab  52件: Rituximab; Rituximab (rituxan); Mabthera (rituximab); Mabthera or biosimilar rituximab product; Rituximab infusion; Rituximab it; Rituximab iv; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Rituximab (mabthera® or rituxan®).; Rituximab and cyclophosphamide iv; Rituximab (arm a); Rituximab (arm b); Abatacept, rituximab or tocilizumab; Abp 798 - biosimilar to rituximab; Gp2013 - a proposed biosimilar rituximab; Idec-c2b8 (rituximab); Mabthera® (rituximab); Originator rituximab - rituxan ® or mabthera ®; Rituxan (inn: rituximab), brand name in the united states; Rituxan® (rituximab); Rituximab - mabthera; Rituximab [mabthera/rituxan]; Rituximab [mabthera]; Rituximab mabthera; Rituximab, mtx, folic acid; Rituximab, observational study amon patients with active ra; Rituximab-eu+ rituximab-pfizer x 2 courses; Rituximab-pfizer (pf-05280586) x 3 courses; Rituximab-us + rituximab-pfizer x 2 courses; Sait101 (proposed rituximab biosimilar); Individualized dose of rituximab; Rituxan (rituximab); Standard dose of rituximab; Administration of rituximab and methylprednisolone; Rituximab (anti-cd20); Alemtuzumab and rituximab; Bendamustine, rituximab; Mabthera or biosimilar rituximab; Rituximab (mabthera®); Alemtuzumab, rituximab; Dexamethasone and rituximab; Rhtpo in combination with rituximab; Immunosuppressive treatment (eg, rituximab); Rituximab (rtx) and azathioprine (aza); Intravenous rituximab; Combined plasma exchange (pex), rituximab, and corticosteroids; The standard steroid treatment, plasma exchange and rituximab; Rituximab 1g iv; Rituximab combined with omalizumab; Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab); Rituximab/ mabthera; Rituximab or rituximab hyaluronidase human;   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331
 21   Rozanolixizumab  1件: Rozanolixizumab;   -   -   -   2件:
11,
14
 22   Sodium chloride  14件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); Sodium chloride; Sodium chloride solution; Isotonic sodium chloride solution; 0.9% sodium chloride injection; Physiological serum (sodium chloride); Sodium chloride solvent; Sodium chloride solution 0.9%; 0.9% w/v sodium chloride solution; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 6%; Sodium pyruvate in 0.9% sodium chloride solution;   D02056   -   -   19件:
6,
11,
13,
14,
17,
34,
46,
51,
53,
67,
78,
86,
97,
168,
193,
227,
228,
288,
299
 23   Vorhyaluronidase alfa  0件:   D06604   -   -   3件:
14,
28,
65

先頭へ